Introduction:
Tagrisso 80 mg tablets contain the active substance osimertinib. It is used to treat advanced non-small cell lung cancer (NSCLC) caused by mutations in the epidermal growth factor receptor EFGR T790M. It is also the preferred option for the treatment of advanced lung cancer that has spread to other parts of the body in patients who have not responded to other anticancer drugs.
Usage of Tagrisso 80mg Tablet:
Treatment of non-small cell lung cancer (NSCLC).
Alternative treatments for patients who no longer respond to prior chemotherapy.
How Tagrisso 80 mg Tablet works:
Tagrisso 80MG Tablet targets mutant tumors and works against the abnormal growth of Epidermal Growth Factor Receptor EFGR T790M. Osimertinib helps shrink cancer cells, stops them from growing, and also prevents lung cancer from coming back after the tumor has been removed by surgery.
Interactions with other drugs:
Before treatment, tell your doctor about all medicines you are taking or are taking.
more information:
Keep tablets out of sight and reach of children. Keep at room temperature. Do not use the medicine if the package is damaged.
Contact on 8939169999. For other order medicines online and pharmaceutical help checkout MrMed.
Σχόλια